Shares of Immunoprecise Antibodies (NASDAQ:IPA), also known as IPA, were up 30% Thursday after its subsidiary BioStrand unveiled an advanced foundation AI model for drug discovery that utilizes large ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback